Chemours Co (CC) : University Of Notre Dame Du Lac added new position in Chemours Co during the most recent quarter end. The investment management firm now holds 198,274 shares of Chemours Co which is valued at $2,270,237 , the company said in a statement filed on Aug 12, 2016 with the SEC.Chemours Co makes up approximately 1.99% of University Of Notre Dame Du Lac’s portfolio.
Other Hedge Funds, Including , First Fiduciary Investment Counsel sold out all of its stake in CC during the most recent quarter. The investment firm sold 24,972 shares of CC which is valued $285,929. Quadrature Capital Ltd added CC to its portfolio by purchasing 147,428 company shares during the most recent quarter which is valued at $1,688,051. Chemours Co makes up approx 0.12% of Quadrature Capital Ltd’s portfolio.Focused Wealth Management Inc reduced its stake in CC by selling 32 shares or 5.42% in the most recent quarter. The Hedge Fund company now holds 558 shares of CC which is valued at $6,389.Amg National Trust Bank reduced its stake in CC by selling 1,545 shares or 2.72% in the most recent quarter. The Hedge Fund company now holds 55,221 shares of CC which is valued at $493,124. Chemours Co makes up approx 0.04% of Amg National Trust Bank’s portfolio. World Asset Management Inc added CC to its portfolio by purchasing 10,925 company shares during the most recent quarter which is valued at $97,560.
Chemours Co opened for trading at $12.68 and hit $13.42 on the upside on Monday, eventually ending the session at $13.27, with a gain of 4.82% or 0.61 points. The heightened volatility saw the trading volume jump to 26,58,417 shares. Company has a market cap of $2,409 M.
On the company’s financial health, Chemours Co reported $0.27 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Aug 8, 2016. Analyst had a consensus of $0.17. The company had revenue of $1383.00 million for the quarter, compared to analysts expectations of $1418.96 million. The company’s revenue was down -8.3 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $-0.10 EPS.
The Chemours Company (Chemours) is a provider of performance chemicals. The Company delivers solutions with a range of industrial and specialty chemical products for markets including plastics and coatings refrigeration and air conditioning general industrial and mining and oil refining. The Company operates through three segments: Titanium Technologies Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2) under the brands including Ti-Pure and Vantage. Its Fluoroproducts segment is a provider of fluoroproducts under the brands including Suva ISCEON Freon Opteon Teflon Tefzel Viton Krytox Formacel Dymel FM 200 Nafion and Capstone. Its Chemical Solutions segment is a provider of industrial and specialty performance chemicals under the brands including Virkon and Oxone. The Company’s products include titanium dioxide refrigerants industrial fluoropolymer resins sodium cyanide sulfuric acid and aniline.